Overall, in breast and ovarian cancer screening programs for women in China, incorporating BRCA1/2 genetic testing for individuals with a family history, along with appropriate preventive measures for those who test positive, increases the population’s QALY by 0.26 days. The gene discussed is BRCA1; the disease is ovarian carcinoma.